Clinical Trial Update: Abbreviated Biparametric MRI (RSI + T2WI) for Prostate Cancer Detection: Correlation With Histopathology [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating abbreviated biparametric MRI (RSI + T2WI) for prostate cancer detection has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: WITHDRAWN